30 Apr 2025 European Immunization Week 2025: Humanly possible Under the theme “Immunization for all is Humanly Possible”, this year’s campaign highlights the urgent need to achieve high and…
18 Apr 2025 How to improve pertussis vaccination in pregnancy: a European expert review How to improve pertussis vaccination in pregnancy: a European expert review Pertussis (whooping cough) remains a serious threat to infants,…
11 Apr 2025 New Research Boosts Future Whooping Cough Vaccines Whooping cough, or pertussis, was once a leading cause of death for children in the U.S. and worldwide before the…
29 Mar 2025 Skin patch delivery of a SARS-CoV-2 spike DNA vaccine produces broad neutralising antibody responses Skin patch delivery of a SARS-CoV-2 spike DNA vaccine produces broad neutralising antibody responses Since the emergence of severe acute…
28 Mar 2025 Infant Responses to Primary Immunization Following Vaccination in Pregnancy With Varying Doses of Recombinant Acellular Pertussis Vaccine Alone or Combined With Tetanus-Diphtheria Infant Responses to Primary Immunization Following Vaccination in Pregnancy With Varying Doses of Recombinant Acellular Pertussis Vaccine Alone or Combined…
25 Feb 2025 Thailand Leads the Way with World’s First Stand-alone Pertussis Vaccine Program for Pregnant Women Thailand Leads the Way with World's First Stand-alone Pertussis Vaccine Program for Pregnant Women Thailand's National Health Security Office (NHSO)…
17 Jan 2025 BioNet Wins BARDA Patch Forward Prize for Microneedle mRNA Vaccine Innovation Lyon, France & Bangkok, Thailand – January 17, 2025 – BioNet, a global leader in vaccine innovation, proudly announces its…
13 Jan 2025 LTS and BioNet Win U.S. BARDA Patch Forward Prize Competition LTS and BioNet Win U.S. BARDA Patch Forward Prize Competition Andernach – LTS, a leading pharmaceutical technology company, and BioNet,…
21 Dec 2024 A reduced-dose recombinant pertussis vaccine booster in Thai adolescents: a phase 2/3, observer-blinded, randomised controlled, non-inferiority trial A reduced-dose recombinant pertussis vaccine booster in Thai adolescents: a phase 2/3, observer-blinded, randomised controlled, non-inferiority trial Pertussis, also known…
05 Dec 2024 Pertussis Immunity 5 Years After Booster Vaccination With Recombinant Pertussis Vaccines Pertussis Immunity 5 Years After Booster Vaccination With Recombinant Pertussis Vaccines Pertussis remains one of the least controlled vaccine-preventable diseases.…
31 Jul 2024 BioNet’s Recombinant Pertussis Vaccine Submitted to European Medicines Agency (EMA) BioNet’s Recombinant Pertussis Vaccine Submitted to European Medicines Agency (EMA) "Monovalent recombinant acellular pertussis vaccine proven to significantly boost immunity…
25 Jul 2024 Transplacental transfer of maternal antibodies following immunization with recombinant pertussis vaccines during pregnancy: Real-world evidence Pertussis, caused by Bordetella pertussis, is a highly contagious respiratory disease that poses a significant risk to young infants, resulting in both severe morbidity…
20 Jul 2023 Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing…
11 Jul 2023 A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women…
01 Apr 2022 A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age A phase 2 randomized-controlled safety and immunogenicity trial evaluating different doses of recombinant acellular pertussis vaccine containing genetically-inactivated pertussis toxin…
